Percival Barretto-Ko

Senior Vice President, International Operations

Percival Barretto-Ko is senior vice president, international operations, for Astellas. In this role, Barretto-Ko leads Astellas Pharma Canada, Astellas Farma Brasil, Astellas Farma Colombia and over 20 countries where Astellas’ innovative therapies serve unmet patient needs. Barretto-Ko is a member of the Astellas Management Committee and Portfolio Strategy Executive Committee.

Prior to assuming this position, Barretto-Ko was senior vice president, corporate strategy and government affairs, where he led the company’s corporate strategy organization comprised of business development, corporate strategy, corporate planning, alliance management, project management, and government affairs. Previously, Barretto-Ko led Astellas Pharma Europe’s corporate strategy organization, headquartered in London, United Kingdom.

Before joining Astellas, Barretto-Ko held increasingly senior commercial positions with the Roche Group in the United States and United Kingdom.

Barretto-Ko earned a Bachelor of Science in biological sciences from Cornell University, a Master of Business Administration from Yale School of Management and a Master of Science from MIT Sloan School of Management, where he served as a Sloan Fellow for Innovation and Global Leadership. 

Barretto-Ko is a member of the International Senior Executive Committee (ISEC) of Pharmaceutical Research and Manufacturers of America (PhRMA). He also serves as a member of the Federación Latinoamericana de la Industria Farmacéutica (FIFARMA) Executive Committee and sits on the BIO International Advisory Steering Committee (IASC). Previously, Barretto-Ko was a board member of the Illinois Innovation Council and the Illinois Expert Advisory Council from 2011-2015, appointed by former Illinois governor Pat Quinn. He also served as a board member of the Illinois Biotechnology Industry Organization (iBIO), an organization that supports educational and entrepreneurial efforts in the life sciences, from 2013-2015.

Copyright © 2005 - 2018 Astellas Pharma US, Inc.